Clasp Therapeutics
Developer of a precision oncology platform designed to support the development of targeted therapies for hard-to-treat cancers. The company's platform identifies tumor-specific neoantigens from oncoge...
Valuation
$0
Share Price
N/A
Total Raised
$150M
Last Round
N/A